These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15392158)

  • 1. [A case of chronic myeloid leukemia treated with ehtylurethane; two cases of malignant granuloma treated with chloramine].
    MASUELLI L
    Minerva Med; 1949 Sep; 40(44 Pt 2):297-9. PubMed ID: 15392158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple successive and simultaneous treatment in a case of chronic myeloid leukemia].
    CAPPELLO F
    Prog Med (Napoli); 1951 Apr; 7(8):217. PubMed ID: 14844498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case report of chronic myeloid leukemia in an infant treated with urethane].
    PADRON RUIZ E
    Rev Cubana Pediatr; 1950 Dec; 22(12):751-64. PubMed ID: 14808860
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of chronic myeloid leukemia in an infant, treated with urethane].
    SCARIZZA PM
    Minerva Pediatr; 1950 Jun; 2(6):278-84. PubMed ID: 15438884
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myelogenous leukemia treated with urethane; report of a case.
    CLAUDY WD
    Med Ann Dist Columbia; 1949 Apr; 18(4):185-7. PubMed ID: 18116360
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged urethane therapy of chronic myeloid leukemia].
    BAUR E
    Arch Inn Med; 1951 Mar; 1(6):692-8. PubMed ID: 24540628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic myeloid leukemia with urethane].
    PLOOIJ M; SMIT SIBINGA A
    Med Maandbl; 1950 May; 3(5):195-8. PubMed ID: 24538157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic myeloid leukemia treated with urethanes, medical clinical note].
    D'ORS JP
    Med Cir Guerra; 1949; 11(11-12):530-2. PubMed ID: 15409041
    [No Abstract]   [Full Text] [Related]  

  • 9. Urethane in chronic myeloid leukaemia.
    PINEY A
    Lancet; 1947 Nov; 2(6482):774. PubMed ID: 20271227
    [No Abstract]   [Full Text] [Related]  

  • 10. Urethane in treatment of chronic myelogenous leukemia.
    CRONE RI; ULRICH DM
    Northwest Med; 1949 Apr; 48(4):252-4. PubMed ID: 18117365
    [No Abstract]   [Full Text] [Related]  

  • 11. Urethane in the treatment of chronic myelogenous leukemia.
    CRONE RL; ULRICH DM
    Bull U S Army Med Dep; 1948 Aug; 8(8):636-40. PubMed ID: 18876396
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pathologic anatomy of chronic myelosis as effected by urethane therapy].
    MASSHOFF W; HEINZEL W
    Dtsch Med Wochenschr; 1950 Dec; 75(51):1722-6. PubMed ID: 14802153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical observations on urethane therapy of chronic myelosis during the last 5 years].
    MICHEL H
    Munch Med Wochenschr; 1952 Jan; 94(3):117-23. PubMed ID: 14919426
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethyl carbamate (urethane) in the treatment of chronic myelocytic leukemia; results of a three-year study.
    COOPER T; WATKINS CH
    Med Clin North Am; 1950 Jul; 34(4):1205-15. PubMed ID: 15429439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary results of combined urethane, nitrogen mustard and Delbet's vaccine therapy of chronic myelocytic leukemias].
    SZREDER W; MIGDALSKA Z
    Pol Tyg Lek (Wars); 1951 May; 6(18-19):620-4. PubMed ID: 14875527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of chloramine in two cases of leukemic myelosis and in a case of malignant lymphogranuloma].
    PAVAN S
    Minerva Med; 1949 Sep; 40(44 Pt 2):287. PubMed ID: 15406620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-hematological variations and stages of chronic myelosis].
    GEIRO SB
    Ter Arkh; 1955; 27(6):3-10. PubMed ID: 13299131
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].
    GARCIGA CE
    Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241
    [No Abstract]   [Full Text] [Related]  

  • 19. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease associated with chronic myeloid leukemia. Determination of bcr-abl rearrangement in paraffin-embedded tumors using the polymerase chain reaction.
    Takimoto Y; Tanabe O; Kuramoto A; Sasaki N; Nanba K
    Acta Haematol; 1994; 92(2):97-100. PubMed ID: 7817711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.